95 related articles for article (PubMed ID: 2219757)
1. [Changes in magnesium and ionized calcium serum levels in disorders of glucose tolerance].
Zamrazil V; Simecková A; Vána V; Bednár J; Vondra K
Vnitr Lek; 1990 Jun; 36(6):531-6. PubMed ID: 2219757
[TBL] [Abstract][Full Text] [Related]
2. Changes of calcemia and magnesemia during oral glucose tolerance test (OGTT) in relation to glucose tolerance.
Simecková A; Zamrazil V; Cerovská J; Stolba P
Endocr Regul; 1994 Dec; 28(4):205-9. PubMed ID: 7711298
[TBL] [Abstract][Full Text] [Related]
3. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
4. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
Rajamand N; Ungerstedt U; Brismar K
Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
[TBL] [Abstract][Full Text] [Related]
6. Serum sialic acid in subjects with impaired glucose tolerance and in newly diagnosed type 2 diabetic patients.
Gavella M; Lipovac V; Car A; Vucić M; Sokolić L; Rakos R
Acta Diabetol; 2003 Jun; 40(2):95-100. PubMed ID: 12861408
[TBL] [Abstract][Full Text] [Related]
7. Inorganic phosphate-insulin relationships in normal subjects and in patients with moderate glucose intolerance.
Campillo JE; Aguayo J; Pages I; Castillo M; Osorio C
Diabete Metab; 1982 Dec; 8(4):289-93. PubMed ID: 6761184
[TBL] [Abstract][Full Text] [Related]
8. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients.
Saha H; Harmoinen A; Pietilä K; Mörsky P; Pasternack A
Clin Nephrol; 1996 Nov; 46(5):326-31. PubMed ID: 8953122
[TBL] [Abstract][Full Text] [Related]
10. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
11. [Development of disorders of glucose tolerance in the offspring of diabetic parents].
Dvoráková L
Vnitr Lek; 1990 Jul; 36(7):660-8. PubMed ID: 2247967
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.
Djurhuus MS; Vaag A; Altura BM; Altura BT; Klitgaard NA
Diabetes Metab; 2002 Jun; 28(3):201-7. PubMed ID: 12149600
[TBL] [Abstract][Full Text] [Related]
13. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
[TBL] [Abstract][Full Text] [Related]
14. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
15. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
16. [The effect of a short-term reducing diet on the effect of insulin in type 2 diabetes mellitus].
Sindelka G; Skrha J; Hilgertová J; Justová V
Cas Lek Cesk; 1997 Sep; 136(17):530-2. PubMed ID: 9441013
[TBL] [Abstract][Full Text] [Related]
17. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
Succurro E; Marini MA; Grembiale A; Lugarà M; Andreozzi F; Sciacqua A; Hribal ML; Lauro R; Perticone F; Sesti G
Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
[TBL] [Abstract][Full Text] [Related]
18. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
20. Diabetogenic effect of triamcinolone in man with impaired thyroid function: serum free fatty acids, inorganic phosphorus, calcium and total protein pattern after an oral glucose load.
Zamrazil V; Nĕmec J; Felt V; Havelka J; Nedvédková J
Endokrinologie; 1976 Oct; 68(1):86-94. PubMed ID: 1001272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
